Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Q32 Bio Charts.

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Q32 Bio Charts.

Q32 Bio Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 11 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday 10 December 2024 (2 weeks ago) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Thursday 7 November 2024 (2 months ago) • PR Newswire (US)

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Tuesday 5 November 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 16 October 2024 (2 months ago) • Edgar (US Regulatory)

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
Monday 14 October 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 10 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 September 2024 (3 months ago) • Edgar (US Regulatory)

More Q32 Bio Inc News Articles

NLBNPIT1Y839 20991231 36...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions